Immune checkpoint inhibitors: friend or foe for osteoporosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Immune checkpoint inhibitors: friend or foe for osteoporosis

Published:2023-01 Issue: Volume:14 Page:204201882311571
ISSN:2042-0188
Container-title:Therapeutic Advances in Endocrinology and Metabolism
language:en
Short-container-title:Therapeutic Advances in Endocrinology

Author:

Tang Jun¹^ORCID

Affiliation:

1. Department of Endocrinology, Zhongnan Hospital of Wuhan University, 169 East Lake Rd., Wuhan 430071, China

Funder

Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund

Fundamental Research Funds for the Central Universities

Hubei Provincial Natural Science Foundation

Publisher

SAGE Publications

Subject

Endocrinology, Diabetes and Metabolism

Link

http://journals.sagepub.com/doi/pdf/10.1177/20420188231157194

Reference10 articles.

1. Immune-checkpoint inhibitors: long-term implications of toxicity

2. Osteoclast Immunosuppressive Effects in Multiple Myeloma: Role of Programmed Cell Death Ligand 1

3. Potential diagnostic value of PD‐1 in peripheral blood mononuclear cells of postmenopausal osteoporosis patients

4. The deficiency of immunoregulatory receptor PD-1 causes mild osteopetrosis

5. PD-1 blockade inhibits osteoclast formation and murine bone cancer pain

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Musculoskeletal adverse events induced by immune checkpoint inhibitors: a large-scale pharmacovigilance study;Frontiers in Pharmacology;2023-10-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP